These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18800959)

  • 1. Intravenous tezosentan and vardenafil attenuate acute hypoxic pulmonary hypertension.
    Geiger R; Treml B; Kleinsasser A; Neu N; Fischer V; Stein JI; Loeckinger A
    High Alt Med Biol; 2008; 9(3):223-7. PubMed ID: 18800959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
    Hedelin P; Kylhammar D; Rådegran G
    Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury.
    Persson BP; Rossi P; Weitzberg E; Oldner A
    Shock; 2009 Oct; 32(4):427-34. PubMed ID: 19197226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous tezosentan improves gas exchange and hemodynamics in acute lung injury secondary to meconium aspiration.
    Geiger R; Kleinsasser A; Meier S; Neu N; Pajk W; Fischer V; Treml B; Stein JI; Loeckinger A
    Intensive Care Med; 2008 Feb; 34(2):368-76. PubMed ID: 17898997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
    Lundgren J; Kylhammar D; Hedelin P; Rådegran G
    Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs.
    Wang L; Zhu DM; Su X; Bai CX; Ware LB; Matthay MA
    Exp Lung Res; 2004; 30(1):31-42. PubMed ID: 14967602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
    Tsai BM; Turrentine MW; Sheridan BC; Wang M; Fiore AC; Brown JW; Meldrum DR
    Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDS.
    Giacomini M; Borotto E; Bosotti L; Denkewitz T; Reali-Forster C; Carlucci P; Centanni S; Mantero A; Iapichino G
    Anaesth Intensive Care; 2007 Feb; 35(1):91-3. PubMed ID: 17323673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vardenafil ameliorates calcium mobilization in pulmonary artery smooth muscle cells from hypoxic pulmonary hypertensive mice.
    Chen WS; Li XQ; Cao W; Xiao X; Dong L; Zhang JZ
    Arch Med Res; 2012 May; 43(4):265-73. PubMed ID: 22704850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
    Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
    Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.
    Torre-Amione G; Young JB; Durand J; Bozkurt B; Mann DL; Kobrin I; Pratt CM
    Circulation; 2001 Feb; 103(7):973-80. PubMed ID: 11181472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration.
    Geiger R; Pajk W; Neu N; Maier S; Kleinsasser A; Fratz S; Navarro-Psiha S; Fischer V; Treml B; Loeckinger A
    Pediatr Res; 2006 Jan; 59(1):147-50. PubMed ID: 16327003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary bypass is associated with altered vascular reactivity of isolated pulmonary artery in a porcine model: therapeutic potential of inhaled tezosentan.
    Mommerot A; Denault AY; Dupuis J; Carrier M; Perrault LP
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):698-708. PubMed ID: 24917060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response of intravenous sildenafil on systemic and regional hemodynamics in hypoxic neonatal piglets.
    Haase E; Bigam DL; Cravetchi O; Cheung PY
    Shock; 2006 Jul; 26(1):99-106. PubMed ID: 16783205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
    Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
    Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension.
    Lourenço AP; Vasques-Nóvoa F; Oliveira-Pinto J; Fontoura D; Roncon-Albuquerque R; Leite-Moreira AF
    Intensive Care Med; 2012 Jun; 38(6):1050-60. PubMed ID: 22349420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension.
    Sandqvist A; Henrohn D; Egeröd H; Hedeland M; Wernroth L; Bondesson U; Schneede J; Wikström G
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1165-73. PubMed ID: 26242227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock.
    Somell A; Weitzberg E; Suneson A; Sollevi A; Hjelmqvist H
    Acta Physiol (Oxf); 2007 Aug; 190(4):291-302. PubMed ID: 17498196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.